ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,778.10
0.00%
S&P ASX All Technology
3,094.00
0.00%
Brent Oil
84.845
1.13%
US Dollar vs AUD
1.50245
-0.54%
Bitcoin
64,951.67
-2.30%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Dor Biopharma (DOR)

  7. Dor Biopharma (DOR) News

DOR

Dor (DOR)

Dor Biopharma
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:DOR
DateTimeSourceHeadlineSymbolCompany
07/04/200623:19Business WireDOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex ExpressionAMEX:DORDor Biopharma
07/04/200605:28Business WireDOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional InvestorsAMEX:DORDor Biopharma
31/03/200601:00Business WireDOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBecAMEX:DORDor Biopharma
09/02/200601:25Business WireDOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)AMEX:DORDor Biopharma
31/01/200609:48Business WireDOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and WellAMEX:DORDor Biopharma
26/01/200602:31Business WireDOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone AheaAMEX:DORDor Biopharma
21/01/200600:10Business WireDOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); ResAMEX:DORDor Biopharma
20/01/200601:26Business WireDOR BioPharma Secures $6 Million Equity Commitment from Fusion CapitalAMEX:DORDor Biopharma
16/11/200501:04Business WireDOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBecAMEX:DORDor Biopharma
15/11/200508:26Business WireDOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for NAMEX:DORDor Biopharma
07/11/200523:00Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceAMEX:DORDor Biopharma
02/11/200522:00Business WireDOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics PipelineAMEX:DORDor Biopharma
02/11/200508:34Business WireDOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-AAMEX:DORDor Biopharma
14/10/200523:17Business WireDOR BioPharma Provides Update on Programs and Corporate MattersAMEX:DORDor Biopharma
16/09/200507:41PR Newswire (US)Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR BioAMEX:DORDor Biopharma
27/07/200503:07PR Newswire (US)DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum ToxinAMEX:DORDor Biopharma
15/06/200520:30Business WireDOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin VaccineAMEX:DORDor Biopharma
14/06/200501:14Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity ConferenceAMEX:DORDor Biopharma
05/05/200500:51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
05/05/200500:51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
04/05/200522:30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
04/05/200522:30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
08/01/200500:30PR Newswire (US)DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)AMEX:DORDor Biopharma
 Showing the most relevant articles for your search:AMEX:DOR

Your Recent History

NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
NAB
National Australia Bank
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
ASX
WBC
Westpac Banking
ASX
XJO
S&P ASX 200
NASDAQ
GOOGL
Alphabet
ASX
BHP
BHP
PM
XAUUSD
Gold vs US Dollar
FX
AUDUSD
AUD vs US Dollar
ASX
ORG
Origin Energy
NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved